Literature DB >> 8214226

HIV-1 seroprevalence and risk behaviors in an urban African-American community cohort.

A F Brunswick1, A Aidala, J Dobkin, J Howard, S P Titus, J Banaszak-Holl.   

Abstract

OBJECTIVES: Previous attempts at obtaining population estimates of human immunodeficiency virus type 1 (HIV-1) seroprevalence have been beset by problems of cooperation bias. As part of the fourth round of study with an urban African-American community cohort, the following investigation was aimed at assessing HIV-1 prevalence and the relative importance of sex and drug injection as risk factors in infection.
METHODS: Personal interviews were conducted in the home with 364 respondents, followed by voluntary blood sample collection from 287 of these individuals.
RESULTS: Blood assays showed a point prevalence of 8.4% HIV-1 seropositivity in this community cross section, with a higher female-to-male ratio than appears among acquired immunodeficiency syndrome (AIDS) case reports. Most infected persons were unaware and unsuspecting of their infection.
CONCLUSIONS: First, findings underscore the need to focus on risk behaviors rather than on risk groups. Second, the smaller than 2:1 ratio of infected men to women suggests that current AIDS case reports seriously underestimate HIV-1 infection among certain cohorts of African-American women. Finally, widespread ignorance of own infected status and inaccurate risk assessment signal the substantial task for community health educators in reaching inner-city African-American men and women at risk.

Entities:  

Mesh:

Year:  1993        PMID: 8214226      PMCID: PMC1694854          DOI: 10.2105/ajph.83.10.1390

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  7 in total

1.  Comparison of saliva and serum for HIV surveillance in developing countries.

Authors:  R R Frerichs; M T Htoon; N Eskes; S Lwin
Journal:  Lancet       Date:  1992 Dec 19-26       Impact factor: 79.321

2.  Health and substance use behavior: the longitudinal Harlem Health Study.

Authors:  A F Brunswick
Journal:  J Addict Dis       Date:  1991

3.  HIV surveillance by testing saliva.

Authors:  A M Johnson; J V Parry; S J Best; A M Smith; M de Silva; P P Mortimer
Journal:  AIDS       Date:  1988-10       Impact factor: 4.177

4.  Epidemiology of HIV infection and AIDS in the United States.

Authors:  J W Curran; H W Jaffe; A M Hardy; W M Morgan; R M Selik; T J Dondero
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

5.  Female-to-male transmission of human immunodeficiency virus.

Authors:  N S Padian; S C Shiboski; N P Jewell
Journal:  JAMA       Date:  1991-09-25       Impact factor: 56.272

6.  A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City.

Authors:  R L Stoneburner; D C Des Jarlais; D Benezra; L Gorelkin; J L Sotheran; S R Friedman; S Schultz; M Marmor; D Mildvan; R Maslansky
Journal:  Science       Date:  1988-11-11       Impact factor: 47.728

7.  Sensitive assays for viral antibodies in saliva: an alternative to tests on serum.

Authors:  J V Parry; K R Perry; P P Mortimer
Journal:  Lancet       Date:  1987-07-11       Impact factor: 79.321

  7 in total
  3 in total

1.  Race and the treatment of cytomegalovirus retinitis in a cohort of patients with acquired immunodeficiency syndrome.

Authors:  A K Wutoh; J Hidalgo; J Bareta; W Rhee; R Beardsley; S Steidl
Journal:  J Natl Med Assoc       Date:  1998-04       Impact factor: 1.798

2.  Injection drug use among homeless adults with severe mental illness.

Authors:  E Susser; P Betne; E Valencia; S M Goldfinger; A F Lehman
Journal:  Am J Public Health       Date:  1997-05       Impact factor: 9.308

3.  Methods for successful follow-up of elusive urban populations: an ethnographic approach with homeless men.

Authors:  S Conover; A Berkman; A Gheith; R Jahiel; D Stanley; P A Geller; E Valencia; E Susser
Journal:  Bull N Y Acad Med       Date:  1997
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.